THERAVANCE BIOPHARMA INC

Ticker: TBPH CUSIP: G8807B106 Class: Common Stock

Opaleye Management Inc.'s Holding History (CIK: 0001595855)

Note: Option positions (PUT/CALL) are excluded.

Q2 2023

Shares 543,500 Value ($000) $5,625 Avg Close $11.04 Range $9.98 - $12.03

Q1 2023

Shares 546,304 Value ($000) $5,927 Avg Close $10.57 Range $9.25 - $11.52

Q4 2022

Shares 87,600 Value ($000) $983 Avg Close $10.51 Range $9.56 - $11.83

Q3 2017

Shares 180,000 Value ($000) $6,163 Avg Close $32.70 Range $23.15 - $42.61

Q2 2017

Shares 180,000 Value ($000) $7,171 Avg Close $38.45 Range $34.85 - $43.44

Q1 2017

Shares 180,000 Value ($000) $6,627 Avg Close $31.95 Range $27.80 - $37.18

Q4 2016

Shares 158,200 Value ($000) $5,043 Avg Close $31.02 Range $24.54 - $38.92

Period	Shares	Value ($000)	Average Close	Price Range
Q2 2023	543,500	$5,625	$11.04	$9.98 - $12.03
Q1 2023	546,304	$5,927	$10.57	$9.25 - $11.52
Q4 2022	87,600	$983	$10.51	$9.56 - $11.83
Q3 2017	180,000	$6,163	$32.70	$23.15 - $42.61
Q2 2017	180,000	$7,171	$38.45	$34.85 - $43.44
Q1 2017	180,000	$6,627	$31.95	$27.80 - $37.18
Q4 2016	158,200	$5,043	$31.02	$24.54 - $38.92